• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Activated ras oncogenes in human thyroid cancers.

作者信息

Lemoine N R, Mayall E S, Wyllie F S, Farr C J, Hughes D, Padua R A, Thurston V, Williams E D, Wynford-Thomas D

机构信息

Department of Pathology, University of Wales College of Medicine, Heath Park, Cardiff, United Kingdom.

出版信息

Cancer Res. 1988 Aug 15;48(16):4459-63.

PMID:3293774
Abstract

Human thyroid epithelial (follicular) cells give rise to two malignant tumors--"follicular" carcinomas, which metastasize almost exclusively via the bloodstream, and "papillary" carcinomas, which metastasize predominantly via lymphatics (Williams, E. D. In: W. Duncan (ed.), Recent Results in Cancer Research: Thyroid Cancer, pp. 47-55. Berlin: Springer-Verlag, 1980). We have investigated whether this contrast in biological behavior might be associated with different patterns of oncogene activation. DNA transfection analysis of five follicular and ten papillary cancers indeed showed a statistically significant difference in the pattern of genes responsible, activated ras oncogenes being found in 80% of follicular tumors but only 20% of papillary tumors. In addition, in follicular cancers we have found activation of all three ras oncogenes (H-ras, K-ras, and N-ras), the first time that this has been demonstrated in a primary human tumor type (as opposed to cell lines). We suggest therefore that ras activation may be an important determinant of metastatic capability in these epithelial cancers.

摘要

相似文献

1
Activated ras oncogenes in human thyroid cancers.
Cancer Res. 1988 Aug 15;48(16):4459-63.
2
Detection of activated ras oncogenes in human thyroid carcinomas.
Oncogene. 1988 Apr;2(4):403-6.
3
ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer.RAS 突变与甲状腺癌的侵袭性肿瘤表型及不良预后相关。
J Clin Oncol. 2003 Sep 1;21(17):3226-35. doi: 10.1200/JCO.2003.10.130.
4
Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas.在转基因小鼠中,N-ras(Gln61Lys)癌基因靶向甲状腺会导致滤泡性肿瘤发展为低分化癌。
Oncogene. 2006 Aug 31;25(39):5467-74. doi: 10.1038/sj.onc.1209527. Epub 2006 Jun 19.
5
Pattern of ras and gsp oncogene mutations in radiation-associated human thyroid tumors.
Oncogene. 1995 Aug 3;11(3):601-3.
6
Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident.切尔诺贝利核事故后受辐射儿童的良性和恶性甲状腺肿瘤中ras和p53基因突变的发生率。
Oncogene. 1996 Aug 15;13(4):687-93.
7
Radiation-associated and 'spontaneous' human thyroid carcinomas show a different pattern of ras oncogene mutation.与辐射相关的和“自发的”人类甲状腺癌显示出不同模式的ras癌基因突变。
Oncogene. 1991 Mar;6(3):471-3.
8
Ha-ras oncogene (codon 12) mutation in thyroid carcinogenesis: analysis of 60 benign and malignant thyroid tumors.甲状腺癌发生过程中Ha-ras癌基因(密码子12)突变:60例甲状腺良恶性肿瘤分析
Ann Biol Clin (Paris). 1995;53(10-11):549-55.
9
Molecular genetic study comparing follicular variant versus classic papillary thyroid carcinomas: association of N-ras mutation in codon 61 with follicular variant.比较滤泡型与经典型乳头状甲状腺癌的分子遗传学研究:第61密码子N-ras突变与滤泡型的关联
Hum Pathol. 2006 Jul;37(7):824-30. doi: 10.1016/j.humpath.2006.01.030. Epub 2006 May 19.
10
[Demonstration of activated oncogenes of the ras family in human thyroid tumors using the polymerase chain reaction].
Verh Dtsch Ges Pathol. 1990;74:415-8.

引用本文的文献

1
Revisionist history uncovers a simplified molecular-based classification of differentiated thyroid cancer.修正主义历史揭示了一种基于分子的分化型甲状腺癌简化分类。
J Pathol. 2025 Oct;267(2):130-141. doi: 10.1002/path.6456. Epub 2025 Aug 5.
2
Detection of genetic mutations in 855 cases of papillary thyroid carcinoma by next generation sequencing and its clinicopathological features.采用下一代测序技术检测 855 例甲状腺乳头状癌中的基因突变及其临床病理特征。
Diagn Pathol. 2024 Nov 15;19(1):146. doi: 10.1186/s13000-024-01573-3.
3
RAS-Mutant Follicular Thyroid Tumors: A Continuous Challenge for Pathologists.
RAS 突变型滤泡状甲状腺肿瘤:病理医师面临的持续挑战。
Endocr Pathol. 2024 Sep;35(3):167-184. doi: 10.1007/s12022-024-09812-5. Epub 2024 Jun 18.
4
Molecular signature incorporating the immune microenvironment enhances thyroid cancer outcome prediction.纳入免疫微环境的分子特征增强甲状腺癌预后预测。
Cell Genom. 2023 Sep 14;3(10):100409. doi: 10.1016/j.xgen.2023.100409. eCollection 2023 Oct 11.
5
Progress in Thyroid Cancer Genomics: A 40-Year Journey.甲状腺癌基因组学的进展:四十年的历程。
Thyroid. 2023 Nov;33(11):1271-1286. doi: 10.1089/thy.2023.0045. Epub 2023 Sep 4.
6
Metabolomics-A Tool to Find Metabolism of Endocrine Cancer.代谢组学——寻找内分泌癌代谢情况的工具。
Metabolites. 2022 Nov 21;12(11):1154. doi: 10.3390/metabo12111154.
7
Evolution of intra-tumoral heterogeneity across different pathological stages in papillary thyroid carcinoma.甲状腺乳头状癌不同病理阶段瘤内异质性的演变
Cancer Cell Int. 2022 Aug 22;22(1):263. doi: 10.1186/s12935-022-02680-1.
8
RET signaling pathway and RET inhibitors in human cancer.人类癌症中的RET信号通路与RET抑制剂
Front Oncol. 2022 Jul 25;12:932353. doi: 10.3389/fonc.2022.932353. eCollection 2022.
9
Papillary Thyroid Cancer Prognosis: An Evolving Field.甲状腺乳头状癌的预后:一个不断发展的领域。
Cancers (Basel). 2021 Nov 7;13(21):5567. doi: 10.3390/cancers13215567.
10
Significance of RAS Mutations in Thyroid Benign Nodules and Non-Medullary Thyroid Cancer.RAS突变在甲状腺良性结节和非髓样甲状腺癌中的意义
Cancers (Basel). 2021 Jul 27;13(15):3785. doi: 10.3390/cancers13153785.